These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 27903937

  • 1. Identification and validation of clinically meaningful benchmarks in the 12-item Multiple Sclerosis Walking Scale.
    Goldman MD, Ward MD, Motl RW, Jones DE, Pula JH, Cadavid D.
    Mult Scler; 2017 Sep; 23(10):1405-1414. PubMed ID: 27903937
    [Abstract] [Full Text] [Related]

  • 2. Japanese translation and validation of the 12-item Multiple Sclerosis Walking Scale version 2.
    Miyazaki Y, Niino M, Takahashi E, Sato C, Naganuma R, Amino I, Akimoto S, Minami N, Kikuchi S.
    Mult Scler Relat Disord; 2024 Sep; 89():105768. PubMed ID: 39003823
    [Abstract] [Full Text] [Related]

  • 3. Cross-cultural adaptation and validation of the 12-item Multiple Sclerosis Walking Scale (MSWS-12) for the Brazilian population.
    Marangoni BE, Pavan K, Tilbery CP.
    Arq Neuropsiquiatr; 2012 Dec; 70(12):922-8. PubMed ID: 23295419
    [Abstract] [Full Text] [Related]

  • 4. Clinically meaningful performance benchmarks in MS: timed 25-foot walk and the real world.
    Goldman MD, Motl RW, Scagnelli J, Pula JH, Sosnoff JJ, Cadavid D.
    Neurology; 2013 Nov 19; 81(21):1856-63. PubMed ID: 24174581
    [Abstract] [Full Text] [Related]

  • 5. Cognitive processing speed has minimal influence on the construct validity of Multiple Sclerosis Walking Scale-12 scores.
    Motl RW, Cadavid D, Sandroff BM, Pilutti LA, Pula JH, Benedict RH.
    J Neurol Sci; 2013 Dec 15; 335(1-2):169-73. PubMed ID: 24104065
    [Abstract] [Full Text] [Related]

  • 6. Multiple Sclerosis Walking Scale-12, translation, adaptation and validation for the Persian language population.
    Nakhostin Ansari N, Naghdi S, Mohammadi R, Hasson S.
    Gait Posture; 2015 Feb 15; 41(2):420-4. PubMed ID: 25444584
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of functional outcome measures after fampridine treatment in patients with multiple sclerosis - An interventional follow-up study.
    Skov CD, Sørensen CB, Thorning M, Lambertsen KL, Frich LH, Jensen HB, Holsgaard-Larsen A, Nielsen HH.
    Mult Scler Relat Disord; 2022 Oct 15; 66():104034. PubMed ID: 35843140
    [Abstract] [Full Text] [Related]

  • 8. Responsiveness and clinically meaningful improvement, according to disability level, of five walking measures after rehabilitation in multiple sclerosis: a European multicenter study.
    Baert I, Freeman J, Smedal T, Dalgas U, Romberg A, Kalron A, Conyers H, Elorriaga I, Gebara B, Gumse J, Heric A, Jensen E, Jones K, Knuts K, Maertens de Noordhout B, Martic A, Normann B, Eijnde BO, Rasova K, Santoyo Medina C, Truyens V, Wens I, Feys P.
    Neurorehabil Neural Repair; 2014 Sep 15; 28(7):621-31. PubMed ID: 24503204
    [Abstract] [Full Text] [Related]

  • 9. Validity of minimal clinically important difference values for the multiple sclerosis walking scale-12?
    Motl RW, Learmonth YC, Pilutti LA, Dlugonski D, Klaren R.
    Eur Neurol; 2014 Sep 15; 71(3-4):196-202. PubMed ID: 24457548
    [Abstract] [Full Text] [Related]

  • 10. The e-MSWS-12: improving the multiple sclerosis walking scale using item response theory.
    Engelhard MM, Schmidt KM, Engel CE, Brenton JN, Patek SD, Goldman MD.
    Qual Life Res; 2016 Dec 15; 25(12):3221-3230. PubMed ID: 27342237
    [Abstract] [Full Text] [Related]

  • 11. Improving our understanding of the most important items of the Multiple Sclerosis Walking Scale-12 indicating mobility dysfunction: Secondary results from a RIMS multicenter study.
    Kalron A, Ehling R, Baert I, Smedal T, Rasova K, Heric-Mansrud A, Elorriage I, Nedeljkovic U, Tachino A, Gargul L, Gusowski K, Cattaneo D, Borgers S, Hebert J, Dalgas U, Feys P.
    Mult Scler Relat Disord; 2020 Nov 15; 46():102511. PubMed ID: 32949848
    [Abstract] [Full Text] [Related]

  • 12. Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III ENHANCE Trial of Prolonged-Release Fampridine.
    Hobart J, Ziemssen T, Feys P, Linnebank M, Goodman AD, Farrell R, Hupperts R, Blight AR, Englishby V, McNeill M, Chang I, Lima G, Elkins J, ENHANCE study investigators.
    CNS Drugs; 2019 Jan 15; 33(1):61-79. PubMed ID: 30535670
    [Abstract] [Full Text] [Related]

  • 13. Confirmation and extension of the validity of the Multiple Sclerosis Walking Scale-12 (MSWS-12).
    Motl RW, Snook EM.
    J Neurol Sci; 2008 May 15; 268(1-2):69-73. PubMed ID: 18061618
    [Abstract] [Full Text] [Related]

  • 14. Mobility, walking and physical activity in persons with multiple sclerosis.
    Kohn CG, Coleman CI, Michael White C, Sidovar MF, Sobieraj DM.
    Curr Med Res Opin; 2014 Sep 15; 30(9):1857-62. PubMed ID: 24803286
    [Abstract] [Full Text] [Related]

  • 15. Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12).
    Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ.
    Neurology; 2003 Jan 14; 60(1):31-6. PubMed ID: 12525714
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of the Multiple Sclerosis Walking Scale-12 (MSWS-12) in a Dutch sample: Application of item response theory.
    Mokkink LB, Galindo-Garre F, Uitdehaag BM.
    Mult Scler; 2016 Dec 14; 22(14):1867-1873. PubMed ID: 26873891
    [Abstract] [Full Text] [Related]

  • 17. Validation of scores from a telephone administered multiple sclerosis walking scale-12 in persons with multiple sclerosis.
    Motl RW, Plummer P, Backus D, Hebert JR, Neal WN, Ng A, Lowman J, Bethoux F, Schmidt H, McBurney R, McCully KK, Cutter G.
    Mult Scler Relat Disord; 2024 Aug 14; 88():105715. PubMed ID: 38889558
    [Abstract] [Full Text] [Related]

  • 18. Multi-group measurement invariance of the multiple sclerosis walking scale-12?
    Motl RW, Mullen S, McAuley E.
    Neurol Res; 2012 Mar 14; 34(2):149-52. PubMed ID: 22333366
    [Abstract] [Full Text] [Related]

  • 19. Performed and perceived walking ability in relation to the Expanded Disability Status Scale in persons with multiple sclerosis.
    Langeskov-Christensen D, Feys P, Baert I, Riemenschneider M, Stenager E, Dalgas U.
    J Neurol Sci; 2017 Nov 15; 382():131-136. PubMed ID: 29111007
    [Abstract] [Full Text] [Related]

  • 20. Responsiveness and clinically meaningful changes for the Persian versions of the multiple sclerosis walking scale-12 and the modified fatigue impact scale following balance and gait rehabilitation in people with multiple sclerosis.
    Monjezi S, Molhemi F, Shaterzadeh Yazdi MJ, Salehi R, Mehravar M, Kashipazha D.
    Physiother Theory Pract; 2022 Mar 15; 38(3):464-470. PubMed ID: 32431220
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.